Waksal Harlan

CIK 00014490084 companiesNEW BRUNSWICK, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001449008

Recent Transactions

50 trades

Award
Lyra Therapeutics, Inc.$LYRA
Performance-based Restricted Stock Units
2024-12-09−128,333→ 0 total
Award
Lyra Therapeutics, Inc.$LYRA
Common Stock
2024-03-18+275,000→ 536,966 total
Purchase
Lyra Therapeutics, Inc.$LYRA
Common Stock
2023-11-10$2.96/sh+25,000→ 261,966 total
Award
Lyra Therapeutics, Inc.$LYRA
Stock Option
2023-01-31+200,000→ 200,000 total
Award
Lyra Therapeutics, Inc.$LYRA
Stock Option
2022-06-16+953,002→ 953,002 total
Purchase
Lyra Therapeutics, Inc.$LYRA
Common Stock
2022-04-12$4.22/sh+236,966→ 236,966 total
Award
Lyra Therapeutics, Inc.$LYRA
Stock Option
2022-02-16+520,000→ 520,000 total
Disposition to Issuer
Kadmon Holdings, Inc.
Stock Appreciation Right
2021-11-09$5.86/sh+655,000→ 0 total
Disposition to Issuer
Kadmon Holdings, Inc.
Stock Option (right to buy)
2021-11-09$5.54/sh+2,000,000→ 0 total
Disposition to Issuer
Kadmon Holdings, Inc.
Performance Stock Option(right to buy)
2021-11-09$5.44/sh+982,500→ 0 total
Disposition to Issuer
Kadmon Holdings, Inc.
Common Stock
2021-11-09$9.50/sh−177,945→ 0 total
Disposition to Issuer
Kadmon Holdings, Inc.
Equity Appreciation Rights Unit
2021-11-09$3.50/sh+750→ 0 total
Disposition to Issuer
Kadmon Holdings, Inc.
Stock Option (right to buy)
2021-11-09$5.35/sh+1,350,000→ 0 total
Award
Kadmon Holdings, Inc.
Common Stock
2021-05-13$3.56/sh+25,000→ 177,945 total
Award
Kadmon Holdings, Inc.
Performance Stock Option (right to buy)
2021-04-03+327,498→ 982,500 total
Award
Kadmon Holdings, Inc.
Stock Option (right to buy)
2021-01-08+2,000,000→ 2,000,000 total
Award
Kadmon Holdings, Inc.
Performance Stock Option (right to buy)
2020-09-10+109,167→ 655,002 total
Purchase
Kadmon Holdings, Inc.
Common Stock, par value $0.001
2020-03-13$2.93/sh+16,000→ 152,945 total
Purchase
Kadmon Holdings, Inc.
Common Stock, par value $0.001
2020-03-11$3.96/sh+12,600→ 136,945 total
Award
Kadmon Holdings, Inc.
Stock Option (right to buy)
2019-11-19+1,350,000→ 1,350,000 total
Award
Kadmon Holdings, Inc.
Stock Option (right to buy)
2019-11-19+1,350,000→ 1,350,000 total
Award
Kadmon Holdings, Inc.
Performance Stock Option (right to buy)
2019-10-24+109,167→ 545,835 total
Award
Kadmon Holdings, Inc.
Performance Stock Option (right to buy)
2019-09-10+109,167→ 436,668 total
Award
Kadmon Holdings, Inc.
Performance Stock Option (right to buy)
2019-06-14+109,167→ 327,501 total
Award
Kadmon Holdings, Inc.
Performance Stock Option (right to buy)
2019-04-03+218,334→ 218,334 total
Award
Kadmon Holdings, Inc.
Common Stock, par value $0.001
2019-03-29$2.25/sh+7,716→ 124,345 total
Award
Kadmon Holdings, Inc.
Common Stock, par value $0.001
2018-09-28$2.84/sh+5,882→ 116,629 total
Award
Kadmon Holdings, Inc.
Stock Appreciation Right
2017-12-08+655,000→ 655,000 total
Purchase
Kadmon Holdings, Inc.
Common Stock, par value $0.001
2017-08-10$2.27/sh+5,000→ 110,747 total
Purchase
Kadmon Holdings, Inc.
Common Stock, par value $0.001
2017-08-08$2.34/sh+3,707→ 105,747 total
Purchase
Kadmon Holdings, Inc.
Common Stock, par value $0.001
2016-11-16$6.37/sh+2,000→ 102,040 total
Purchase
Kadmon Holdings, Inc.
Common Stock, par value $0.001
2016-11-14$6.79/sh+2,000→ 100,040 total
Award
Eloxx Pharmaceuticals, Inc.
Company Stock Option
2015-11-19$0.25/sh+40,000→ 40,000 total
Award
Eloxx Pharmaceuticals, Inc.
Common Stock Option
2015-05-18$0.97/sh+11,340→ 147,693 total
Award
Eloxx Pharmaceuticals, Inc.
Common Stock Option
2015-02-19$0.54/sh+26,552→ 136,353 total
Award
Eloxx Pharmaceuticals, Inc.
Common Stock Option (right to buy)
2014-11-18$0.42/sh+17,168→ 109,500 total
Award
Eloxx Pharmaceuticals, Inc.
Common Stock Option (right to buy)
2014-11-18+38,034→ 92,332 total
Award
Eloxx Pharmaceuticals, Inc.
Common Stock Option
2013-09-13+530,000→ 3,236,572 total
Award
Eloxx Pharmaceuticals, Inc.
Common Stock Option
2013-09-13+530,000→ 3,236,572 total
Award
Eloxx Pharmaceuticals, Inc.
Common Stock Option
2013-05-17+273,256→ 2,716,572 total
Award
Eloxx Pharmaceuticals, Inc.
Common Stock Option
2013-02-19+145,834→ 2,433,316 total
Award
Eloxx Pharmaceuticals, Inc.
Common Stock Options
2012-11-16+420,000→ 2,122,330 total
Award
Eloxx Pharmaceuticals, Inc.
Common Stock Options
2012-11-16+165,152→ 2,287,482 total
Conversion
Eloxx Pharmaceuticals, Inc.
Series B Convertible Preferred Stock
2012-08-08−200→ 0 total
Conversion
Eloxx Pharmaceuticals, Inc.
Common Stock
2012-08-08$0.26/sh+858,517→ 2,805,750 total
Award
Eloxx Pharmaceuticals, Inc.
Common Stock Option
2012-05-16+46,342→ 1,702,330 total
Award
Eloxx Pharmaceuticals, Inc.
Common Stock Option
2012-02-16+45,834→ 1,655,988 total
Purchase
Eloxx Pharmaceuticals, Inc.
Common Stock
2012-01-06$0.26/sh+961,538→ 1,902,590 total
Award
Eloxx Pharmaceuticals, Inc.
Common Stock Option
2011-11-16+147,500→ 1,610,154 total
Award
Eloxx Pharmaceuticals, Inc.
Common Stock Option
2011-09-30+305,000→ 1,462,654 total

Companies

Recent Filings

Address

303 GEORGE STREET SUITE 420

NEW BRUNSWICK, NJ, 08901

View on SEC.gov